|
Eisai pharmaceuticals job opportunity information for careers in fields such as sales, finance and research and development. ... About Eisai ... Home / Eisai Careers / Career Opportunities...
|
www.eisai.com/job.asp?ID=145
www.eisai.com/job.asp?ID=145
|
|
|
Eisai - Wikipedia, the free encyclopedia
|
|
Myōan Eisai (明菴栄西) (April 20, 1141–July 5, 1215) was a Japanese Buddhist priest, credited with bringing the Rinzai school of Zen Buddhism and green tea from China to Japan. He is often known simply a...
en.wikipedia.org/wiki/Eisai
|
|
|
Diversity of Abstracts Reflects Continued Growth of Eisai's Commitment to Oncology ... The expansion of Eisai's oncology discovery, research and clinical development capabilities complements the company's establishment of its oncology sales and marketing operations in the United States.
|
www.drugs.com/clinical_trials/clinical-data-eisai-s-onc...
www.drugs.com/clinical_trials/clinical-data-eisai-s-oncology-pipeline-presented-asco-annual-meeting-1061.html
|
|
|
"We are pleased that Eisai accepts the value of Materia's technology in drug discovery and process chemistry and look forward to its exciting progress," stated Dr. Michael Giardello, Materia's Chief Executive Officer.
|
www.drugs.com/clinical_trials/materia-licenses-metathes...
www.drugs.com/clinical_trials/materia-licenses-metathesis-catalyst-platform-eisai-1384.html
|
|
Eisai Co. - Wikipedia, the free encyclopedia
|
|
Eisai Co., Ltd. is one of the leading global pharmaceutical companies, ranking among the top 25 and achieving $8 billion USD in sales for the fiscal 2008 year. Headquartered in Tokyo, Japan, it has s...
en.wikipedia.org/wiki/Eisai_Co.
|
|
We demonstrated that tienilic acid, a diuretic drug withdrawn from the market because of hepatic failure, enhanced hyperbilirubinemia in Eisai hyperbilirubinuria rats (EHBR) with a defect of canalicular multidrug resistance-associated protein 2 (Mrp2). ... The Medscape Journal ... Allergy & Clinical Immunology...
|
www.medscape.com/medline/abstract/16543292
|
|
The Medscape Journal ... METHODS: Ramatroban was intravenously or orally administered to Sprague-Dawley rats (SDR) and Eisai hyperbilirubinemic rats (EHBR).
|
www.medscape.com/medline/abstract/15212172
|
|
At Eisai Research Institute, we benefit patients through innovative drug discovery research. ... At Eisai Research Institute (ERI), we dedicate our first thoughts to the lives of patients and their families. Benefiting patients through innovative drug discovery research is at the heart of our human health care...
|
www.eisairesearch.com/
www.eisairesearch.com/
|
|
Hoovers company profile of Eisai Co., Ltd.. Find detailed business information such as key executives, financials and other corporate data on Eisai Co., Ltd.. ... Eisai develops, manufactures, and distributes prescription pharmaceuticals, primarily in North America and Japan. Prescription drug sales account for a majority...
|
www.hoovers.com/company/Eisai_Co_Ltd/hjtxti-1.html
www.hoovers.com/company/Eisai_Co_Ltd/hjtxti-1.html
|
|
